Bayer and Samsung take action against sleep disturbances associated with menopause
Sleep disturbances are among the most frequent and disruptive symptoms associated with menopause which can impact women’s health and quality of life
Sleep disturbances are among the most frequent and disruptive symptoms associated with menopause which can impact women’s health and quality of life
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
Launch of 20 new medicines expected by 2030
Sanofi will leverage this partnership to provide access to proprietary data to develop AI models
Additional data from APPRAISE ATP trial reinforce modular therapy approach
The collaboration aims to bolster healthcare entrepreneurship
Subscribe To Our Newsletter & Stay Updated